SignatureFD’s Xenon Pharmaceuticals XENE Stock Holding History

SignatureFD’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.2K	Buy	553 +80	+17%	+$3.69K	﹤0.01%	1969
2025 Q4	$21.2K	Buy	473 +57	+14%	+$2.39K	﹤0.01%	2098
2025 Q3	$16.7K	Sell	416 -245	-37%	-$8.63K	﹤0.01%	2195
2025 Q2	$20.7K	Buy	661 +476	+257%	+$15.5K	﹤0.01%	2040
2025 Q1	$6.21K	Sell	185 -386	-68%	-$14.7K	﹤0.01%	2518
2024 Q4	$22.4K	Buy	571 +334	+141%	+$13.8K	﹤0.01%	2012
2024 Q3	$9.33K	Buy	237 +108	+84%	+$4.36K	﹤0.01%	2360
2024 Q2	$5.03K	Hold	129	–	–	﹤0.01%	2515
2024 Q1	$5.55K	Hold	129	–	–	﹤0.01%	2504
2023 Q4	$5.94K	Buy	129 +125	+3,125%	+$4.42K	﹤0.01%	2450
2023 Q3	$137	Sell	4 -9	-69%	-$337	﹤0.01%	3129
2023 Q2	$501	Sell	13 -20	-61%	-$795	﹤0.01%	3072
2023 Q1	$1.18K	Buy	+33	New	+$1.22K	﹤0.01%	2945

Other funds holding XENE

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return